IMM Immupharma Plc

    RNS Number : 8920X
  Immupharma PLC
  30 June 2008
   

 For Immediate Release  30 June 2008


        
    ImmuPharma PLC

    Annual Report and Accounts


    In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms
that the Annual Report and Accounts for the year ended 31 December 2007, has been posted to shareholders. 

    The annual report is available, in electronic form, for download on the Company's website www.immupharma.com. 
    

For further information please contact: 

 ImmuPharma PLC: 
 Dimitri Dimitriou, Chief Executive Officer  +44 20 7152 4080
 Richard Warr, Chairman                      +44 20 7152 4080

 Buchanan Communications                     + 44 20 7466 5000
 Lisa Baderoon
 Rebecca Skye Dietrich

 Panmure Gordon & Co
 Andrew Burnett                              +44 151 243 0963



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
ACSFMMJTMMIJBAP

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024